Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/131636
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
| Type: | Journal article |
| Title: | Response to Dahl et al: Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes |
| Author: | Horowitz, M. Rayner, C.K. Marathe, C.S. Wu, T. Umapathysivam, M. Jones, K.L. |
| Citation: | Diabetes, Obesity and Metabolism: a journal of pharmacology and therapeutics, 2021; 23(10):2411-2413 |
| Publisher: | Wiley |
| Issue Date: | 2021 |
| ISSN: | 1462-8902 1463-1326 |
| Statement of Responsibility: | Michael Horowitz, Christopher K. Rayner, Chinmay S. Marathe, Tongzhi Wu, Mahesh Umapathysivam, Karen L. Jones |
| Abstract: | Abstract not available. |
| Keywords: | Humans Diabetes Mellitus, Type 2 Glucose Gastric Emptying Postprandial Period Lipid Metabolism Glucagon-Like Peptides |
| Description: | Letter to the Editor |
| Rights: | © 2021 John Wiley & Sons Ltd |
| DOI: | 10.1111/dom.14473 |
| Grant ID: | NHMRC |
| Published version: | http://dx.doi.org/10.1111/dom.14473 |
| Appears in Collections: | Aurora harvest 4 Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.